NewAmsterdam PREVAIL Interim Faces 'Considerable' Risk, RBC SaysMT Newswires2026. 10. 06. 00:34
RBC Cuts Price Target on NewAmsterdam Pharma to $42 From $50, Keeps Outperform, Speculative RiskMT Newswires2026. 10. 05. 19:59
Group 1 Automotive and 4 More Stocks See Action From Activist InvestorsBarrons.com2026. 10. 03. 07:02
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire2026. 10. 03. 05:01
NewAmsterdam Pharma Doses First Participant in Phase 2b Trial for Preclinical Alzheimer's DiseaseMT Newswires2026. 09. 29. 23:23
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s DiseaseGlobeNewswire2026. 09. 29. 21:00

조회 2026. 10. 12. 03:16 · KST